- Home
- LOVE vs KPTI Comparison
LOVE vs KPTI Comparison
Compare LOVE & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LOVE | KPTI |
|---|---|---|
| Founded | 1998 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 193.2M | 172.6M |
| IPO Year | 2018 | 2013 |
Fundamental Metrics
Financial Performance| Metric | LOVE | KPTI |
|---|---|---|
| Price | $14.04 | $5.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | ★ $27.60 | $15.33 |
| AVG Volume (30 Days) | 328.4K | ★ 1.3M |
| Earning Date | 03-26-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $680,628,000.00 | $146,067,000.00 |
| Revenue This Year | $7.65 | N/A |
| Revenue Next Year | $8.77 | $46.62 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 0.57 |
| 52 Week Low | $10.33 | $3.51 |
| 52 Week High | $21.90 | $10.99 |
Technical Indicators
Market Signals| Indicator | LOVE | KPTI |
|---|---|---|
| Relative Strength Index (RSI) | 65.93 | 29.62 |
| Support Level | $14.04 | $3.93 |
| Resistance Level | $15.26 | $6.82 |
| Average True Range (ATR) | 0.74 | 0.86 |
| MACD | 0.43 | -0.36 |
| Stochastic Oscillator | 90.75 | 9.41 |
Price Performance
Historical ComparisonAbout LOVE The Lovesac Company
The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.
About KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).